Veracyte Q4 Earnings Call Highlights [Yahoo! Finance]
Veracyte, Inc. (VCYT)
Last veracyte, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.veracyte.com/investor-relations
Company Research
Source: Yahoo! Finance
double-digit revenue growth, expanding profitability and progress toward multiple new product launches planned for 2026. Fourth-quarter and full-year performance Chief Executive Officer Marc Stapley said fourth-quarter total revenue was $141 million , representing 19% year-over-year growth . He attributed the performance to strength in the company's core testing business, which grew 21% on “strong volume and ASP.” Stapley said Decipher volume rose 21% and Afirma volume increased 12%, contributing to 16% total testing volume growth. ? Hinge Health's AI Moat Might Be Its Patient Movement Data For the full year 2025, Veracyte reported $517 million in total revenue, representing 16% growth and landing at the high end of the company's preliminary range, according to Stapley. He said the company provided “clinically actionable information” to nearly 170,000 patients during the year and has served more than 800,000 patients to date, adding that Veracyte expects to test its 1 milliont
Show less
Read more
Impact Snapshot
Event Time:
VCYT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VCYT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VCYT alerts
High impacting Veracyte, Inc. news events
Weekly update
A roundup of the hottest topics
VCYT
News
- Veracyte (VCYT) had its price target raised by Needham & Company LLC from $44.00 to $48.00. They now have a "buy" rating on the stock.MarketBeat
- Veracyte outlines 10%–13% revenue growth for 2026 while advancing MRD and Prosigna launches [Seeking Alpha]Seeking Alpha
- Veracyte (VCYT) Q4 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Veracyte: Q4 Earnings Snapshot [Yahoo! Finance]Yahoo! Finance
- Veracyte Announces Fourth Quarter and Full Year 2025 Financial ResultsBusiness Wire
VCYT
Earnings
- 2/25/26 - Beat
VCYT
Sec Filings
- 2/26/26 - Form 10-K
- 2/25/26 - Form 8-K
- 2/5/26 - Form SCHEDULE
- VCYT's page on the SEC website